Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 19

The DOI matches its Crossref record.

Tuning the structural coupling between the transmembrane and cytoplasmic domains of phospholamban to control sarcoplasmic reticulum Ca2+-ATPase (SERCA) function

Ha, Kim N., Gustavsson, Martin, Veglia, Gianluigi · 2012 · Journal of Muscle Research and Cell Motility

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10974-012-9319-4

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 45

  1. Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415:198–205 · DOI · Paper page
  2. Bers DM (2008) Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70:23–49 · DOI · Paper page
  3. Buck B, Zamoon J, Kirby TL, DeSilva TM, Karim C, Thomas D, Veglia G (2003) Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies. Protein Expr Purif 30:253–261 · DOI · Paper page
  4. Chu G, Lester JW, Young KB, Luo W, Zhai J, Kranias EG (2000) A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists. J Biol Chem 275:38938–38943 · DOI · Paper page
  5. Fabiato A, Fabiato F (1978) Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat and frog hearts and from fetal and new-born rat ventricles. Ann N Y Acad Sci 307:491–522 · DOI · Paper page
  6. Farrow N, Muhandiram R, Singer A, Pascal S, Kay C, Gish G, Shoelson S, Pawson T, Forman-Kay J, Kay L (1994) Backbone dynamics of a free and a phosphopeptide-complexed Src homology 2 domain studied by 15 N NMR relaxation. Biochemistry 33:5984–6003 · DOI · Paper page
  7. Gustavsson M, Traaseth NJ, Karim CB, Lockamy EL, Thomas DD, Veglia G (2011a) Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca(2+)-ATPase. J Mol Biol 408(4):755–765 · DOI · Paper page
  8. Gustavsson M, Traaseth NJ, Veglia G (2011b) Activating and deactivating roles of lipid bilayers on the Ca(2+)-ATPase/phospholamban complex. Biochemistry 50(47):10367–10374 · DOI · Paper page
  9. Gustavsson M, Traaseth NT, Veglia G (2011c) Probing ground and excited states of phospholamban in model and native lipid membranes by magic angle spinning NMR spectroscopy. Biochim Biophys Acta 1818:146–153 · DOI · Paper page
  10. Ha KN, Traaseth NJ, Verardi R, Zamoon J, Cembran A, Karim CB, Thomas DD, Veglia G (2007) Controlling the inhibition of the sarcoplasmic Ca2+-ATPase by tuning phospholamban structural dynamics. J Biol Chem 282:37205–37214 · DOI · Paper page
  11. Ha KN, Masterson LR, Hou Z, Verardi R, Walsh N, Veglia G, Robia SL (2011) Lethal arg9cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A. Proc Natl Acad Sci USA 108:2735–2740 · DOI · Paper page
  12. Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW, MacLennan DH, Kremastinos DT, Kranias EG (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin Invest 111:869–876 · DOI · Paper page
  13. Haghighi K, Gregory KN, Kranias EG (2004) Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. Biochem Biophys Res Commun 322:1214–1222 · DOI
  14. Haghighi K, Kolokathis F, Gramolini AO, Waggoner JR, Pater L, Lynch RA, Fan GC, Tsiapras D, Parekh RR, Dorn GW, MacLennan DH, Kremastinos DT, Kranias EG (2006) A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci USA 103:1388–1393 · DOI · Paper page
  15. Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Gu Y, Iwatate M, Li M, Wang L, Wilson JM, Wang Y, Ross J, Chien KR (2002) Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8:864–871 · DOI · Paper page
  16. Hoshijima M, Knoll R, Pashmforoush M, Chien KR (2006) Reversal of calcium cycling defects in advanced heart failure toward molecular therapy. J Am Coll Cardiol 48:A15–A23 · doi:10.1016/j.jacc.2006.06.070
  17. Johnson BA (2004) Using NMRview to visualize and analyze the NMR spectra of macromolecules protein NMR techniques. Methods Mol Biol 278:313–352
  18. Karim CB, Marquardt CG, Stamm JD, Barany G, Thomas DD (2000) Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase. Biochemistry 39:10892–10897 · DOI · Paper page
  19. Karim CB, Kirby TL, Zhang Z, Nesmelov Y, Thomas DD (2004) Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone. Proc Natl Acad Sci USA 101:14437–14442 · DOI
  20. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R, Mariani JA, Pepe S, Chien KR, Power JM (2007) Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 50:253–260 · DOI · Paper page
  21. Kelly EM, Hou Z, Bossuyt J, Bers DM, Robia SL (2008) Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells. J Biol Chem 283:12202–12211 · DOI
  22. Kimura Y, Asahi M, Kurzydlowski K, Tada M, MacLennan DH (1998) Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum. J Biol Chem 273:14238–14241 · DOI · Paper page
  23. Li J, Boschek CB, Xiong Y, Sacksteder CA, Squier TC, Bigelow DJ (2005) Essential role for Pro21 in phospholamban for optimal inhibition of the Ca-ATPase. Biochemistry 44:16181–16191 · doi:10.1021/bi051075o
  24. MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566–577 · DOI · Paper page
  25. MacLennan DH, Kimura Y, Toyofuku T (1998) Sites of regulatory interaction between calcium ATPases and phospholamban. Ann N Y Acad Sci 853:31–42 · doi:10.1111/j.1749-6632.1998.tb08254.x
  26. Masterson LR, Mascioni A, Traaseth NJ, Taylor SS, Veglia G (2008) Allosteric cooperativity in protein kinase A. Proc Natl Acad Sci USA 105:506–511 · DOI · Paper page
  27. Masterson LR, Yu T, Shi L, Wang Y, Gustavsson M, Mueller MM, Veglia G (2011) cAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban. J Mol Biol 412:155–164 · DOI · Paper page
  28. Medeiros A, Biagi DG, Sobreira TJ, de Oliveira PS, Negrao CE, Mansur AJ, Krieger JE, Brum PC, Pereira AC (2011) mutations in the human phospholamban gene in patients with heart failure. Am Heart J 162(6):1088–1095.e1 · DOI
  29. Metcalfe EE, Zamoon J, Thomas DD, Veglia G (2004) (1)H/(15)N heteronuclear NMR spectroscopy shows four dynamic domains for phospholamban reconstituted in dodecylphosphocholine micelles. Biophys J 87:1205–1214 · DOI · Paper page
  30. Metcalfe EE, Traaseth NJ, Veglia G (2005) Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban. Biochemistry 44:4386–4396 · DOI
  31. Palmer AG, Kroenke CD, Loria JP (2001) Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules. Methods Mol Biol 339:204–238
  32. Reddy LG, Cornea RL, Winters DL, McKenna E, Thomas DD (2003) Defining the molecular components of calcium transport regulation in a reconstituted membrane system. Biochemistry 42:4585–4592 · DOI · Paper page
  33. Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, Kranias EG, MacLennan DH, Seidman JG, Seidman CE (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299:1410–1413 · DOI · Paper page
  34. Shanmugam M, Gao S, Hong C, Fefelova N, Nowycky MC, Xie LH, Periasamy M, Babu GJ (2011) Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility. Cardiovasc Res 89:353–361 · DOI
  35. Simmerman HK, Jones LR (1998) Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78:921–947 · DOI · Paper page
  36. Simmerman HK, Kobayashi YM, Autry JM, Jones LR (1996) A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J Biol Chem 271:5941–5946 · DOI · Paper page
  37. Tilemann L, Ishikawa K, Weber T, Hajjar R (2012) Gene therapy for heart failure. Circ Res 110(5):777–793 · DOI
  38. Toyoshima C, Nakasako M, Nomura H, Ogawa H (2000) Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 405:647–655 · DOI · Paper page
  39. Traaseth NJ, Veglia G (2010) Probing excited states and activation energy for the integral membrane protein phospholamban by NMR CPMG relaxation dispersion experiments. Biochem Biophys Acta 1798:77–81 · DOI · Paper page
  40. Traaseth NJ, Ha KN, Verardi R, Shi L, Buffy JJ, Masterson LR, Veglia G (2008) Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase. Biochemistry 47:3–13 · DOI
  41. Traaseth NJ, Shi L, Verardi R, Mullen DG, Barany G, Veglia G (2009) Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach. Proc Natl Acad Sci USA 106:10165–10170 · DOI · Paper page
  42. Trieber CA, Afara M, Young HS (2009) Effects of phospholamban transmembrane mutants on the calcium affinity, maximal activity, and cooperativity of the sarcoplasmic reticulum calcium pump. Biochemistry 48(39):9287–9296 · DOI
  43. Veglia G, Ha KN, Shi L, Verardi R, Traaseth NJ (2010) What can we learn from a small regulatory membrane protein? Methods Mol Biol 654:303–319 · doi:10.1007/978-1-60761-762-4_16
  44. Verardi R, Shi L, Traaseth NJ, Walsh N, Veglia G (2011) Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method. Proc Natl Acad Sci USA 108:9101–9106 · DOI · Paper page
  45. Zamoon J, Mascioni A, Thomas DD, Veglia G (2003) NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys J 85:2589–2598 · doi:10.1016/s0006-3495(03)74681-5

Cited by

See all 19

Metadata

Authors
Ha, K. N., Gustavsson, M., & Veglia, G.
Venue
Journal of Muscle Research and Cell Motility
Published
2012-09-13
Volume
33
Issue
6
Pages
485-492
ISSN
  • 0142-4319
  • 1573-2657
Cited by
19
References
0
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tuning the structural coupling between the transmembrane and cytoplasmic domains of phospholamban to control sarcoplasmic reticulum Ca2+-ATPase (SERCA) function. https://app.cochat.ai/papers/10.1007/s10974-012-9319-4
The paper
Ha, K. N., Gustavsson, M., & Veglia, G. (2012). Tuning the structural coupling between the transmembrane and cytoplasmic domains of phospholamban to control sarcoplasmic reticulum Ca2+-ATPase (SERCA) function. Journal of Muscle Research and Cell Motility. https://doi.org/10.1007/s10974-012-9319-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.